CSS LLC/IL - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$432,000
+79.3%
9,605
+88.3%
0.02%
-5.3%
Q1 2020$241,000
-98.3%
5,100
-97.9%
0.02%
-97.6%
Q4 2019$14,517,000
+493.7%
240,335
+489.2%
0.80%
+412.1%
Q3 2019$2,445,000
+194.2%
40,789
+215.6%
0.16%
+234.0%
Q2 2019$831,000
-11.8%
12,923
+11.4%
0.05%
-16.1%
Q1 2019$942,000
-56.1%
11,600
-70.8%
0.06%
-61.1%
Q4 2018$2,147,000
-8.8%
39,700
-13.0%
0.14%
+42.6%
Q3 2018$2,354,000
+208.1%
45,636
+149.4%
0.10%
+180.6%
Q2 2018$764,000
-40.2%
18,300
-36.9%
0.04%
-42.9%
Q1 2018$1,278,000
-15.4%
29,000
-3.3%
0.06%
-14.9%
Q4 2017$1,510,000
-6.7%
30,000
-6.1%
0.07%
-7.5%
Q3 2017$1,619,000
+293.9%
31,937
+212.1%
0.08%
+220.0%
Q1 2017$411,000
+6.2%
10,232
+26.3%
0.02%
+19.0%
Q4 2016$387,000
+30.7%
8,1000.0%0.02%
+50.0%
Q3 2016$296,000
+39.6%
8,100
-11.0%
0.01%0.0%
Q2 2016$212,000
-35.2%
9,100
+12.3%
0.01%
-30.0%
Q1 2016$327,000
-82.2%
8,100
-72.6%
0.02%
-81.5%
Q4 2015$1,834,00029,6000.11%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders